Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220794855> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4220794855 endingPage "378" @default.
- W4220794855 startingPage "371" @default.
- W4220794855 abstract "Cisplatin-based neoadjuvant chemotherapy (NAC) is the standard of care in non-metastatic muscle-invasive bladder cancer (MIBC). There are limited data regarding the alternative choices for cisplatin-ineligible patients. This study has investigated the oncological outcomes of gemcitabine plus cisplatin (Gem/Cis) and gemcitabine plus carboplatin (Gem/Carbo) in this setting.One hundred forty consecutive patients with MIBC (cT2-T4a) receiving neoadjuvant Gem/Cis or Gem/Carbo before chemoradiation (CRT) or radical cystectomy (RC) were retrospectively evaluated between April 2009 and April 2019. Patients with ECOG performance status 2, creatinine clearance < 60 mL/min, hydronephrosis, ejection fraction < 50%, or single kidney received Gem/Carbo. The complete clinical response (cCR) and overall survival (OS) of NAC regimens were compared. Prognostic significance was assessed with Cox proportional hazards model.In total, 79 patients (56.4%) received Gem/Cis. The cCR was not significantly different between Gem/Cis and Gem/Carbo regimens (38.7% vs. 36.2%, P = .771). After NAC, 79 patients (56.4%) received CRT, and other cases underwent RC. After a median follow-up of 43 months, patients in the Gem/Cis group had significantly better OS than Gem/Carbo (median OS: 41.0 vs. 26.0 months, P = .008). Multivariable Cox proportional hazards models identified cT4a stage (95% confidence interval [95% CI]: 1.001-4.85, hazard ratio [HR] = 2.08, P = .03) and cCR (95% CI: 0.26-0.99, HR = 0.51, P = .04) as the only independent prognostic factors of OS, and ruled out the type of NAC regimen.The choice of NAC (between Gem/Cis and Gem/Carbo) is not the predictor of survival and both regimens had similar cCR." @default.
- W4220794855 created "2022-04-03" @default.
- W4220794855 creator A5021318054 @default.
- W4220794855 creator A5036698930 @default.
- W4220794855 creator A5042158679 @default.
- W4220794855 creator A5051400668 @default.
- W4220794855 creator A5054033603 @default.
- W4220794855 creator A5066590307 @default.
- W4220794855 creator A5074566305 @default.
- W4220794855 creator A5084328533 @default.
- W4220794855 date "2022-11-08" @default.
- W4220794855 modified "2023-09-30" @default.
- W4220794855 title "Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis." @default.
- W4220794855 doi "https://doi.org/10.22037/uj.v19i.6841" @default.
- W4220794855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35246833" @default.
- W4220794855 hasPublicationYear "2022" @default.
- W4220794855 type Work @default.
- W4220794855 citedByCount "0" @default.
- W4220794855 crossrefType "journal-article" @default.
- W4220794855 hasAuthorship W4220794855A5021318054 @default.
- W4220794855 hasAuthorship W4220794855A5036698930 @default.
- W4220794855 hasAuthorship W4220794855A5042158679 @default.
- W4220794855 hasAuthorship W4220794855A5051400668 @default.
- W4220794855 hasAuthorship W4220794855A5054033603 @default.
- W4220794855 hasAuthorship W4220794855A5066590307 @default.
- W4220794855 hasAuthorship W4220794855A5074566305 @default.
- W4220794855 hasAuthorship W4220794855A5084328533 @default.
- W4220794855 hasConcept C121608353 @default.
- W4220794855 hasConcept C126322002 @default.
- W4220794855 hasConcept C126894567 @default.
- W4220794855 hasConcept C143998085 @default.
- W4220794855 hasConcept C167135981 @default.
- W4220794855 hasConcept C207103383 @default.
- W4220794855 hasConcept C2775910329 @default.
- W4220794855 hasConcept C2776694085 @default.
- W4220794855 hasConcept C2778239845 @default.
- W4220794855 hasConcept C2778292576 @default.
- W4220794855 hasConcept C2780258809 @default.
- W4220794855 hasConcept C2780352672 @default.
- W4220794855 hasConcept C2781413609 @default.
- W4220794855 hasConcept C2781451048 @default.
- W4220794855 hasConcept C44249647 @default.
- W4220794855 hasConcept C50382708 @default.
- W4220794855 hasConcept C530470458 @default.
- W4220794855 hasConcept C71924100 @default.
- W4220794855 hasConceptScore W4220794855C121608353 @default.
- W4220794855 hasConceptScore W4220794855C126322002 @default.
- W4220794855 hasConceptScore W4220794855C126894567 @default.
- W4220794855 hasConceptScore W4220794855C143998085 @default.
- W4220794855 hasConceptScore W4220794855C167135981 @default.
- W4220794855 hasConceptScore W4220794855C207103383 @default.
- W4220794855 hasConceptScore W4220794855C2775910329 @default.
- W4220794855 hasConceptScore W4220794855C2776694085 @default.
- W4220794855 hasConceptScore W4220794855C2778239845 @default.
- W4220794855 hasConceptScore W4220794855C2778292576 @default.
- W4220794855 hasConceptScore W4220794855C2780258809 @default.
- W4220794855 hasConceptScore W4220794855C2780352672 @default.
- W4220794855 hasConceptScore W4220794855C2781413609 @default.
- W4220794855 hasConceptScore W4220794855C2781451048 @default.
- W4220794855 hasConceptScore W4220794855C44249647 @default.
- W4220794855 hasConceptScore W4220794855C50382708 @default.
- W4220794855 hasConceptScore W4220794855C530470458 @default.
- W4220794855 hasConceptScore W4220794855C71924100 @default.
- W4220794855 hasIssue "5" @default.
- W4220794855 hasLocation W42207948551 @default.
- W4220794855 hasOpenAccess W4220794855 @default.
- W4220794855 hasPrimaryLocation W42207948551 @default.
- W4220794855 hasRelatedWork W2155839160 @default.
- W4220794855 hasRelatedWork W2317145945 @default.
- W4220794855 hasRelatedWork W2471989939 @default.
- W4220794855 hasRelatedWork W2751375968 @default.
- W4220794855 hasRelatedWork W2792646068 @default.
- W4220794855 hasRelatedWork W2946011640 @default.
- W4220794855 hasRelatedWork W2964723749 @default.
- W4220794855 hasRelatedWork W3144473405 @default.
- W4220794855 hasRelatedWork W3202515919 @default.
- W4220794855 hasRelatedWork W4233827388 @default.
- W4220794855 hasVolume "19" @default.
- W4220794855 isParatext "false" @default.
- W4220794855 isRetracted "false" @default.
- W4220794855 workType "article" @default.